Diagnostic and Clinical Background and Case Management for Suspected Vaccine-induced Immune Thrombotic Thrombocytopenia
April 20, 2021 –
Please join the American Society of Hematology as they share guidance on diagnosis and management of suspected Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) following Johnson & Johnson/Janssen COVID-19 vaccination.
Hosted by the Centers for Disease Control and Prevention (CDC)
You are invited to a Zoom webinar.
Description: Rare cases of thrombosis with thrombocytopenia have been reported following vaccination with the Johnson & Johnson/Janssen COVID-19 vaccine. This one-hour seminar will review the background, diagnosis, and clinical management of this emerging disorder with experts from CDC and the American Society of Hematology, as well as how to report cases through CDC’s Vaccine Adverse Events Reporting System (VAERS).
Please click the link below to join the webinar:
Or One tap mobile:
US: +16692545252,,1600672158#,,,,*810423# or +16468287666,,1600672158#,,,,*810423#
US: +1 669 254 5252 or +1 646 828 7666 or +1 551 285 1373 or +1 669 216 1590
Webinar ID: 160 067 2158
International numbers available: https://www.zoomgov.com/u/achNm2sQkg
Or an H.323/SIP room system:
H.323: 184.108.40.206 (US West) or 220.127.116.11 (US East)
Meeting ID: 160 067 2158